Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)
CNY 66.33
(-2.11%)
CNY 66.33
(-2.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.49 Billion | 962.39 Million | 773.21 Million | 976.65 Million | 831.72 Million | 701.96 Million |
| Net Income | 1.65 Billion | 1.32 Billion | 973.69 Million | 939.14 Million | 772.6 Million | 693.99 Million |
| Depreciation & Amortization | 179.19 Million | 116.48 Million | 97 Million | 79.14 Million | 52.96 Million | 39.57 Million |
| Deferred income taxes | 4.81 Million | 3.15 Million | 18.31 Million | -14.47 Million | -2.21 Million | - |
| Stock-based compensation | - | -80.7 Million | 93.88 Million | 141.4 Million | - | - |
| Change in working capital | -329.65 Million | -304.83 Million | -354.03 Million | -178.41 Million | 20.83 Million | -16.7 Million |
| Other non-cash items | 678.16 Million | -99.61 Million | -55.64 Million | 9.85 Million | -14.68 Million | -14.89 Million |
| Investing Cash Flow | -370.57 Million | -593.71 Million | -924.56 Million | -2.49 Billion | -285.46 Million | -249.57 Million |
| Investments in PPE | -322.19 Million | -403.21 Million | -342.93 Million | -254.81 Million | -327.1 Million | -284.86 Million |
| Acquisitions | 87.79 Thousand | 660.72 Thousand | 243.45 Thousand | 256.59 Million | 327.52 Million | - |
| Investment purchases | -7.5 Billion | -10.19 Billion | -9.61 Billion | -11.76 Billion | -9.59 Billion | -6.63 Billion |
| Sales/Maturities of investments | 7.46 Billion | 10.01 Billion | 9.03 Billion | 9.52 Billion | 9.63 Billion | 6.66 Billion |
| Other Investing Activities | 5 Million | -4.99 Million | 0.88 | -254.81 Million | -327.1 Million | 878.01 Thousand |
| Financing Cash Flow | -568.6 Million | -497.44 Million | -287.43 Million | 653.67 Million | -8.3 Million | -102.36 Million |
| Debt repayment | -16.28 Million | -4.05 Million | -3.59 Million | - | - | - |
| Dividends payments | -550 Million | -471.67 Million | -412.35 Million | -618.98 Million | - | -101.16 Million |
| Common Stock Repurchased | -16.28 Million | -21.61 Million | - | - | - | - |
| Common Stock Issuance | - | 25.67 Million | - | - | -800 Thousand | - |
| Other Financing Activities | 1.79 Million | -25.67 Million | 129.56 Million | 1.27 Billion | -8.3 Million | -1.2 Million |
| Accounts receivables | -277.17 Million | -240.16 Million | -154.65 Million | -60.45 Million | -34.14 Million | -22.82 Million |
| Accounts payables | 84.01 Million | 162.11 Million | 10.02 Million | 119.02 Million | 99.55 Million | - |
| Inventory | -136.48 Million | -229.94 Million | -227.72 Million | -222.51 Million | -42.36 Million | -51.32 Million |
| Other working capital | 88.83 Million | 3.15 Million | 18.31 Million | -14.47 Million | -2.21 Million | 34.61 Million |
| Cash at beginning of period | 483.42 Million | 616.02 Million | 1.06 Billion | 1.96 Billion | 1.43 Billion | 1.08 Billion |
| Cash at end of period | 1.04 Billion | 478.12 Million | 616.02 Million | 1.06 Billion | 1.96 Billion | 1.43 Billion |
| Capital Expenditure | -322.19 Million | -403.21 Million | -342.93 Million | -254.81 Million | -327.1 Million | -284.86 Million |
| Effect of forex changes on cash | 8.69 Million | -9.13 Million | -13.99 Million | -33.48 Million | -2.92 Million | -367.24 Thousand |
| Net cash flow / Change in cash | 564.83 Million | -137.9 Million | -452.78 Million | -897.6 Million | 535.02 Million | 349.65 Million |
| Free Cash Flow | 1.17 Billion | 559.17 Million | 430.27 Million | 721.83 Million | 504.61 Million | 417.1 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 480.44 Million | 476.92 Million | 426.22 Million | 466.94 Million | 1.65 Billion | 436.7 Million |
| Depreciation & Amortization | - | 52.76 Million | 52.76 Million | 49.63 Million | 179.19 Million | -68.27 Million |
| Deferred income taxes | - | - | - | - | 4.81 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -363.45 Million | - | -413.66 Million | -329.65 Million | 287.87 Million |
| Other non-cash items | -135.43 Million | -60.27 Million | -109.19 Million | 420 Million | 678.16 Million | -255.77 Million |
| Investing Cash Flow | -540.78 Million | 157.72 Million | -332.95 Million | -287.08 Million | -370.57 Million | -117.08 Million |
| Investments in PPE | -93.71 Million | -87.55 Million | -138.41 Million | -66.02 Million | -322.19 Million | -57.41 Million |
| Acquisitions | 97.58 Thousand | 640.00 | 3512.00 | 12.15 Thousand | 87.79 Thousand | 7860.00 |
| Investment purchases | -1.71 Billion | -2.31 Billion | -1.74 Billion | -1.49 Billion | -7.5 Billion | -678.03 Million |
| Sales/Maturities of investments | 1.27 Billion | 2.55 Billion | 1.55 Billion | 1.28 Billion | 7.46 Billion | 618.35 Million |
| Other Investing Activities | -381.14 Thousand | 252.44 Million | -139.25 Million | -5 Million | 5 Million | 0.29 |
| Financing Cash Flow | -820.99 Thousand | -787.74 Million | -838.38 Thousand | -1.82 Million | -568.6 Million | -395.11 Thousand |
| Debt repayment | - | - | - | - | -16.28 Million | - |
| Dividends payments | -395.22 Thousand | -785.71 Million | -62.8 Thousand | -550 Million | -550 Million | -718.91 Thousand |
| Common Stock Repurchased | - | - | - | -16.28 Million | -16.28 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.21 Million | 15.87 Thousand | -838.38 Thousand | 568.57 Million | 1.79 Million | 323.8 Thousand |
| Accounts receivables | - | -295.62 Million | - | -277.17 Million | -277.17 Million | 215.56 Million |
| Accounts payables | - | - | - | - | 84.01 Million | - |
| Inventory | - | -67.83 Million | - | -136.48 Million | -136.48 Million | 72.31 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 763.73 Million | 1.02 Billion | 1.04 Billion | 808.05 Million | 483.42 Million | 527.28 Million |
| Cash at end of period | 568.7 Million | 764.52 Million | 1.02 Billion | 1.04 Billion | 1.04 Billion | 806.83 Million |
| Capital Expenditure | -93.71 Million | -87.55 Million | -138.41 Million | -66.02 Million | -322.19 Million | -57.41 Million |
| Effect of forex changes on cash | 6.94 Million | 2.8 Million | -1.93 Million | 4.92 Million | 8.69 Million | -3.49 Million |
| Net cash flow / Change in cash | -195.03 Million | -263.88 Million | -19.85 Million | 240.21 Million | 564.83 Million | 279.54 Million |
| Free Cash Flow | 251.29 Million | 276.33 Million | 178.6 Million | 456.9 Million | 1.17 Billion | 343.1 Million |
5257
1277
200670
CLEU
8623
3825